<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ban on Indian Drug Manufacturers.</title>
    <link>https://www.taxtmi.com/news?id=3213</link>
    <description>No ban on Indian drug manufacturers has been recorded; media allegations of low-quality supplies and suspensions in Sri Lanka led to diplomatic discussions stressing clearer tender technical specifications. Indian exports must meet destination regulatory requirements and Indian manufacturing norms enforced by the Drug Controller General of India, and any violations are addressed under Drugs and Cosmetics Act.</description>
    <language>en-us</language>
    <pubDate>Mon, 07 May 2012 15:54:52 +0530</pubDate>
    <lastBuildDate>Mon, 07 May 2012 15:54:52 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=305952" rel="self" type="application/rss+xml"/>
    <item>
      <title>Ban on Indian Drug Manufacturers.</title>
      <link>https://www.taxtmi.com/news?id=3213</link>
      <description>No ban on Indian drug manufacturers has been recorded; media allegations of low-quality supplies and suspensions in Sri Lanka led to diplomatic discussions stressing clearer tender technical specifications. Indian exports must meet destination regulatory requirements and Indian manufacturing norms enforced by the Drug Controller General of India, and any violations are addressed under Drugs and Cosmetics Act.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Mon, 07 May 2012 15:54:52 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=3213</guid>
    </item>
  </channel>
</rss>